Deceptive Adherence to Anticoagulation in Secondary Stroke Prevention

Table 2

Logistic regression model for factors related to good/full treatment adherence (%).

	Odds ratio ^†	SE	-value	value	95% confidence interval
Age (y)	1.00	0.02	-0.12	0.90	0.95-1.04
Female	1.00
Male	0.79	0.30	-0.64	0.52	0.38-1.64
Recurrent stroke	1.00
First-ever stroke	2.27	0.82	2.26	0.02	1.12-4.61
CHA2DS2-VASc	0.79	0.11	-1.62	0.11	0.60-1.05
HAS-BLED	1.07	0.26	0.29	0.77	0.67-1.72
eGFR	1.00	0.01	0.36	0.72	0.98-1.02
NIHSS at discharge	1.00	0.04	-0.35	0.73	0.92-1.06
Apixaban	1.00
Dabigatran	0.75	0.36	-0.60	0.55	0.29-1.94
Rivaroxaban	0.92	0.36	-0.21	0.84	0.43-1.99
Warfarin	0.63	0.31	-0.93	0.35	0.24-1.65

^†Odds ratios are mutually adjusted for all variables presented in the table. MPR: medication possession ratio; SE: standard error; eGFR: estimated glomerular filtration rate; NIHSS: National Institutes of Health Stroke Scale.